Fuji Pharma Co Ltd
FUP
Company Profile
Business description
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
Contact
5-7 Sanban-cho
Chiyoda-ku
Tokyo102-0075
JPNT: +81 335563344
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 September 2026
Employees
1,760
Stocks News & Analysis
stocks
Wide moat share remains cheap despite rising costs
Higher costs weigh on profits but stronger sales trends support long term outlook.
stocks
Fair value upgrade for ASX listed fast food chain
Earnings beat lifts forecasts but long term growth questions remain.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
We’re expecting another beat-and-raise quarter, while watching the roadmap and discussions of its financing and partnership deals.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,374.90 | 50.40 | 0.54% |
| CAC 40 | 8,446.15 | 6.86 | -0.08% |
| DAX 40 | 26,285.06 | 178.46 | 0.68% |
| Dow JONES (US) | 53,469.58 | 52.42 | 0.10% |
| FTSE 100 | 10,884.94 | 30.62 | 0.28% |
| HKSE | 25,511.10 | 6.23 | -0.02% |
| NASDAQ | 26,125.11 | 144.92 | 0.56% |
| Nikkei 225 | 65,856.43 | 328.34 | 0.50% |
| NZX 50 Index | 13,992.72 | 110.84 | 0.80% |
| S&P 500 | 7,671.85 | 18.99 | 0.25% |
| S&P/ASX 200 | 9,164.60 | 54.30 | 0.60% |
| SSE Composite Index | 3,889.44 | 7.44 | 0.19% |